We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRE
476
DELISTED
Veris Residential
VRE
$24.3K ﹤0.01%
1,287
-106
-8% -$1.8K
BCAX
477
Bicara Therapeutics
BCAX
$1.85B
$24.3K ﹤0.01%
1,220
+144
+13% +$2.48K
SEPN
478
Septerna Inc
SEPN
$1.52B
$24.2K ﹤0.01%
1,006
+128
+15% +$3.37K
ALVO icon
479
Alvotech
ALVO
$1.19B
$24K ﹤0.01%
7,004
+854
+14% +$3.75K
DEI icon
480
Douglas Emmett
DEI
$2.06B
$24K ﹤0.01%
2,549
-215
-8% -$2.21K
EYPT icon
481
EyePoint Inc
EYPT
$1.09B
$24K ﹤0.01%
1,859
+233
+14% +$3.48K
GLUE icon
482
Monte Rosa Therapeutics
GLUE
$2B
$23.9K ﹤0.01%
1,453
+174
+14% +$3.33K
NTST
483
NETSTREIT Corp
NTST
$2.13B
$23.8K ﹤0.01%
1,263
-120
-9% -$2.31K
ZBIO
484
Zenas BioPharma
ZBIO
$2.04B
$23.6K ﹤0.01%
1,205
+151
+14% +$3.39K
COLL icon
485
Collegium Pharmaceutical
COLL
$1.16B
$23.5K ﹤0.01%
711
+91
+15% +$3.85K
ABCL icon
486
AbCellera Biologics
ABCL
$1.82B
$23.4K ﹤0.01%
6,696
+814
+14% +$2.93K
QURE icon
487
uniQure
QURE
$2.76B
$22.7K ﹤0.01%
1,389
+166
+14% +$3.36K
KALV
488
DELISTED
KalVista Pharmaceuticals
KALV
$22.7K ﹤0.01%
1,126
+134
+14% +$2.16K
PEB icon
489
Pebblebrook Hotel Trust
PEB
$2.24B
$22.7K ﹤0.01%
1,794
-183
-9% -$2.24K
INBX icon
490
Inhibrx
INBX
$1.29B
$21.9K ﹤0.01%
326
+41
+14% +$3.04K
GRFS
491
Grifois
GRFS
$5.27B
$21.9K ﹤0.01%
2,725
+329
+14% +$2.9K
PCRX icon
492
Pacira BioSciences
PCRX
$1.01B
$21.9K ﹤0.01%
967
+123
+15% +$2.73K
XHR
493
Xenia Hotels & Resorts
XHR
$1.98B
$21.7K ﹤0.01%
1,465
-122
-8% -$1.84K
XERS icon
494
Xeris Biopharma Holdings
XERS
$1.52B
$21.5K ﹤0.01%
3,710
+450
+14% +$2.98K
IIPR icon
495
Innovative Industrial Properties
IIPR
$1.83B
$21.3K ﹤0.01%
424
-40
-9% -$2.02K
GERN icon
496
Geron
GERN
$924M
$21.2K ﹤0.01%
14,233
+2,080
+17% +$3.16K
AVBP icon
497
ArriVent BioPharma
AVBP
$1.32B
$21.2K ﹤0.01%
919
+108
+13% +$2.44K
COIN icon
498
Coinbase
COIN
$46.3B
$20.6K ﹤0.01%
+118
New +$23.2K
AMPH icon
499
Amphastar Pharmaceuticals
AMPH
$864M
$20.1K ﹤0.01%
1,024
+122
+14% +$2.98K
SILA
500
DELISTED
Sila Realty Trust
SILA
$19.7K ﹤0.01%
834
-82
-9% -$2.01K
18 19
20
21 22

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.